Table 2.
Random effect regression models over 24 weeks. Model 0 unadjusted, and model 1 adjusted for age, sex, and disease duration (n=59; observations=177).
| Assessment | Model 0 | Model 1 | ||||||||
|
|
r (SE) | P value | r (SE) | P value | ||||||
| DLQIa | ||||||||||
|
|
Week 0 | Refb | Ref | Ref | Ref | |||||
|
|
Week 12 | –0.561 (0.205) | .006 | –0.561 (0.205) | .006 | |||||
|
|
Week 24 | –0.855 (0.205) | <.001 | –0.855 (0.205) | <.001 | |||||
|
|
Intervention group | Ref | Ref | Ref | Ref | |||||
|
|
Control group | –0.234 (0.288) | .42 | –0.128 (0.288) | .66 | |||||
|
|
Week 0 × control | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 × control | 0.450 (0.262) | .09 | 0.450 (0.262) | .09 | |||||
|
|
Week 24 × control | 0.420 (0.262) | .11 | 0.420 (0.262) | .11 | |||||
|
|
R2: within | 0.184 (N/Ac) | N/A | 0.184 (N/A) | N/A | |||||
|
|
R2: between | 0.01 (N/A) | N/A | 0.097 (N/A) | N/A | |||||
|
|
R2: overall | 0.059 (N/A) | N/A | 0.125 (N/A) | N/A | |||||
| Pain | ||||||||||
|
|
Week 0 | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 | 0.478 (0.676) | .48 | 0.478 (0.676) | .48 | |||||
|
|
Week 24 | –0.739 (0.676) | .28 | –0.739 (0.676) | .28 | |||||
|
|
Intervention group | Ref | Ref | Ref | Ref | |||||
|
|
Control group | 0.459 (0.723) | .53 | 0.468 (0.737) | .53 | |||||
|
|
Week 0 × control group | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 × control group | 0.105 (0.866) | .90 | 0.105 (0.866) | .90 | |||||
|
|
Week 24 × control group | 0.961 (0.866) | .27 | 0.961 (0.866) | .27 | |||||
|
|
R2: within | 0.038 (N/A) | N/A | 0.038 (N/A) | N/A | |||||
|
|
R2: between | 0.040 (N/A) | N/A | 0.086 (N/A) | N/A | |||||
|
|
R2: overall | 0.039 (N/A) | N/A | 0.064 (N/A) | N/A | |||||
| Activity | ||||||||||
|
|
Week 0 | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 | –1.390 (0.677) | .04 | –1.390 (0.677) | .04 | |||||
|
|
Week 24 | –2.350 (0.677) | .001 | –2.350 (0.677) | <.001 | |||||
|
|
Intervention group | Ref | Ref | Ref | Ref | |||||
|
|
Control group | 0.079 (0.765) | .92 | 0.393 (0.755) | .60 | |||||
|
|
Week 0 × control group | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 × control group | 1.090 (0.867) | .21 | 1.090 (0.867) | .21 | |||||
|
|
Week 24 × control group | 0.987 (0.867) | .26 | 0.987 (0.867) | .26 | |||||
|
|
R2: within | 0.144 (N/A) | N/A | 0.144 (N/A) | N/A | |||||
|
|
R2: between | 0.030 (N/A) | N/A | 0.157 (N/A) | N/A | |||||
|
|
R2: overall | 0.082 (N/A) | N/A | 0.151 (N/A) | N/A | |||||
| HECSId | ||||||||||
|
|
Week 0 | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 | –0.513 (0.229) | .03 | –0.513 (0.229) | .03 | |||||
|
|
Week 24 | –0.715 (0.229) | .002 | –0.715 (0.229) | .002 | |||||
|
|
Intervention group | Ref | Ref | Ref | Ref | |||||
|
|
Control group | –0.158 (0.273) | .56 | –0.062 (0.254) | .81 | |||||
|
|
Week 0 × control group | Ref | Ref | Ref | Ref | |||||
|
|
Week 12 × control group | 0.327 (0.293) | .26 | 0.327 (0.293) | .26 | |||||
|
|
Week 24 × control group | 0.429 (0.293) | .14 | 0.429 (0.293) | .14 | |||||
|
|
R2: within | 0.102 (N/A) | N/A | 0.102 (N/A) | N/A | |||||
|
|
R2: between | 0.01 (N/A) | N/A | 0.286 (N/A) | N/A | |||||
|
|
R2: overall | 0.044 (N/A) | N/A | 0.211 (N/A) | N/A | |||||
aDLQI: Dermatology Life Quality Index.
bRef: reference value.
cN/A: not applicable.
dHECSI: Hand Eczema Severity Index.